Gilead Sciences
RANK
129
Gilead Sciences/AP Images
Company Information
As of 6/5/23
Country
U.S.
Headquarters
Foster City, Calif.
Industry
Pharmaceuticals
CEO
Daniel P. O'Day
Website
Company Type
Public
Ticker
GILD
Revenues ($M)
$27,281
Profits ($M)
$4,592
Market Value ($M)
$103,614
Employees
17,000
Market value as of March 31, 2023.
Key Financials (Last Fiscal Year)
$ millions
% change
Revenues ($M)
$27,305
10.6%
Profits ($M)
$6,225
4961%
Assets ($M)
$67,952
-
Total Stockholder Equity ($M)
$21,069
-
Profit Ratios
Profit as % of Revenues
22.8%
Profits as % of Assets
9.2%
Profits as % of Stockholder Equity
29.5%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)
4.93
EPS % Change (from 2020)
4830%
EPS % Change (5 year annual rate)
-13.1%
EPS % Change (10 year annual rate)
10.8%
Total Return
Total Return to Investors (2021)
29.8%
Total Return to Investors (5 year, annualized)
4%
Total Return to Investors (10 year, annualized)
16%
Gilead Sciences Rank History
Historical Data
Year | Revenues ($M) | Profits ($M) | Assets ($M) | Total Stockholder Equity ($M) |
---|---|---|---|---|
2021 | $24,68910% | $123-97.7% | $68,407 | $18,202 |
2020 | $22,4491.5% | $5,386-1.3% | $61,627 | $22,525 |
2019 | $22,127-15.2% | $5,45517.9% | $63,675 | $21,387 |
2018 | $26,107-14.1% | $4,628-65.7% | $70,283 | $20,442 |
2017 | $30,390-6.9% | $13,501-25.4% | $56,977 | $18,887 |
SHOW MORE
Lists ranking Gilead Sciences
Latest news for Gilead Sciences